Showing results (291-300 of 363) with videos related to
Sort By:
Pageof 37
Urologic Oncology|April 17, 2018
Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomyBrian R Winters, Funda Vakar-Lopez, Lisha Brown, et al.BJU International|May 15, 2014
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective studyIlaria Lucca, Wassim Kassouf, Anil Kapoor, et al.International Journal of Radiation Oncology, Biology, Physics|August 26, 2024
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder CancerPier Paolo Avolio, Ronald Kool, Bobby Shayegan, et al.Nature Communications|January 9, 2021
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancerGillian Vandekerkhove, Jean-Michel Lavoie, Matti Annala, et al.European Urology Oncology|February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant CellsJonathan Chou, Kai Trepka, Martin Sjöström, et al.The Journal of Urology|July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder CancerDaniel Halstuch, Ronald Kool, Gautier Marcq, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features: Initial results from a multi-institutional Canadian studyDavid-Dan Nguyen, Paola V Nasute Fauerbach, Jethro C C Kwong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy SpectrumLucia Nappi, Marisa Thi, Amy Lum, et al.The Journal of Urology|May 18, 2019
Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical CystectomyKristen McAlpine, Luke T Lavallée, Dawn Stacey, et al.Molecular Cancer Therapeutics|September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder CancerTilman Todenhöfer, Roland Seiler, Craig Stewart, et al.Pageof 37